Keith B. Glaser
AbbVie (United States)(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Microtubule and mitosis dynamics, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → The odyssey of marine pharmaceuticals: a current pipeline perspective(2010)652 cited
- Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.(2003)
- → HDAC inhibitors: Clinical update and mechanism-based potential(2007)348 cited
- → Phospholipase A2 enzymes: regulation and inhibition(1993)252 cited
- → Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA(2003)219 cited
- → Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.(1990)206 cited
- → Discovery ofN-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor